No Data
No Data
Mesoblast's Cell Therapy Shows Improved Outcomes in Heart Disease Patients in Phase 3 Study
Revascor Improves Survival and Reduces Major Morbidity in High-Risk Ischemic Heart Failure Patients With Inflammation
Mesoblast Limited's (ASX:MSB) 17% Gain Last Week Benefited Both Retail Investors Who Own 54% as Well as Insiders
JPMorgan Chase Takes Significant Stake in Mesoblast
Mesoblast Announces Director Change and Shareholdings
Mesoblast Limited's AGM Resolutions Gain Strong Approval
Mr Brooks : Thank you. You are amazing. !!!
Trytosaveabit : As you know I’ve been waiting for this 510 clearance! I know most don’t like it! And admittedly the chart and volume are not looking good! Hehehe! But I really like, have like and continue to like MOVE! Hehehe! People don’t realize just how superior this is over the junk you can just buy on Amazon! Hehehe
Jaguar8 OP Trytosaveabit : Yes it took forever for this EvieRing to get cleared even with superior results . Glad they had it
Trytosaveabit Jaguar8 OP : Yup yup! I knew at one point you felt as I do! Not sure where you stand these days? Hehehe.
Jaguar8 OP Trytosaveabit : It was just parked on my FDA watchlist and waited forever
View more comments...